Ireland, Denmark, Norway, Iceland, and the Netherlands had already done it. The pharmaceutical firm confirms that there is no indication that the vaccine raises the risk of clotting.
Countries which reject the use of the corona virus vaccine developed by the AstraZeneca laboratory are still in operation. On Monday, Germany, France, and Italy took the measure as a precaution due to suspicions that the drug may cause blood clots or blood clots.
The German Ministry of Health affirmed that it made the decision based on a current recommendation of the Paul Ehrlich Institute, the government body in charge of vaccines' approval, Who examined that it is important to check the possible relationship between this vaccine and new cases. Of thrombosis registered in Europe after inoculation.
The German institute recommended further research on the vaccine.
The health ministry said it would in any case be the European Medicines Agency that would eventually decide how "if this new information vaccine affects the authority of the vaccine."
For his part, French President Emmanuel Macron announced the suspension of AstraZeneca's vaccine against COVID-19, pending a recommendation from the European Medicines Agency (EMA) on Tuesday.
It has been decided that in order to postpone the AstraZeneca vaccination as a precaution and we hope that if the EMA recommendation is allowed, we will revive it immediately. "Said the macron
Italy also relied on "caution" as a reason to stop vaccination with AstraZeneca, as decided by other European countries due to reports of probable side effects.
A wave of arrest
The Italian Drug Agency (Aifa) specified that the measure was taken "as a precaution and temporarily throughout the territory" while awaiting EMA's decision, the European drug agency, in charge of the evaluation in the European Union.
Thus, these three countries join the decision to stop the use of the AstraZeneca vaccine made by numerous countries in recent days, from the Netherlands, Ireland, Denmark, Norway, and Iceland, which altogether suspended it to Austria, which made only with a few batches.
The EMA has so far identified around thirty cases of thrombosis following a dose of the AstraZeneca vaccine. In total, some five million doses have been administered in the European Union (EU).
The EMA has reported that thrombosis rate among the vaccinated persons is "not higher than the total population ", but he has also stated that it is necessary to analyze whatever has happened in detail.
From the beginning, the third authorized side is weighed with doubts aboutAstraZeneca's effectiveness and possible side effects, which is authorized to do with Moderna/Pfizer and BioNTech in the EU.
After its authorization in the EU, the German government - following the PEI indications - recommended using AstraZeneca only for people between 18 and 64 years old, considering that preliminary tests had been carried out with older people.
Recently, and to accelerate the vaccination campaign, the federal government and the federated states advocated removing this restriction and using AstraZeneca's in the entire population and the other two vaccines against coronavirus.